SynthesisGut2026

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Edo J Dongelmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.